SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09/09 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
22/08/26	EUR 0.0920	-0.54%	227,837
20/08/26	EUR 0.0925	-1.07%	707,099
19/08/26	EUR 0.0935	-4.30%	1,036,711
18/08/26	EUR 0.0977	-11.02%	2,462,112
17/08/26	EUR 0.1098	+24.77%	6,239,187

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 01:55:00 22/08/26 am AEST			5-day change	1st Jan Change
0.0920 ^EUR	-0.54%		+4.55%	-8.91%

28/07	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
28/07	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI

Market Cap	8.68M 10.14M 8.13M 7.44M 13.96M 970M 14.14M 96.01M 37.44M 487M 38.07M 37.24M 1.61B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	8.42M 9.83M 7.88M 7.21M 13.53M 940M 13.71M 93.07M 36.3M 472M 36.91M 36.1M 1.56B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.68%	Yield 2024 *	-	Yield 2025	-

28/07	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
28/07	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
28/07	SpineGuard Secures a New Patent in the United States
09/07	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
08/07	Zonebourse earnings calendar for company results: July 8, 2026
27/05	SpineGuard Secures Three Patent Applications in US	MT
27/05	SpineGuard granted three new patents in the United States
27/05	Spineguard Obtains Three New Patents for Full Protection in the United States of Its Innovative Solutions Integrating Dsg Technology	CI
29/04	SpineGuard Officially Launches Newly Cleared Curved and XS PediGuard Models, in Nanjing	CI
14/04	SpineGuard Transfers US Unit's Assets, Executes Distribution Deal with Omnia Medical	MT
14/04	SpineGuard and Omnia Medical Complete Us Asset Transfer and Enter Exclusive Distribution Agreement for Pediguard Devices	CI
14/04	Omnia Medical, LLC completed the acquisition of Spineguard, Inc. from SpineGuard SA.	CI
09/04	SpineGuard SA Auditor Raises 'Going Concern' Doubt	CI

28/07	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
09/07	SpineGuard Announces its H1 2026 Revenue	BU
27/05	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU
29/04	SpineGuard : Official launch of three New PediGuard® Models during the Annual Scoliosis Meeting in China	PU
29/04	SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China	BU

SpineGuard Stock

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news : SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Course Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

28/07	SpineGuard obtient un nouveau brevet aux Etats-Unis
28/07	SpineGuard et Omnia Medical obtiennent un nouveau brevet américain pour leur application innovante de la technologie DSG à la fusion de l'articulation sacro-iliaque
24/07	SpineGuard : Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF
09/07	SpineGuard en mesure de financer son activité jusqu'au deuxième trimestre 2027
09/07	SpineGuard annonce son chiffre d’affaires du premier semestre 2026

1 day	-0.54%
1 week	+4.55%
Current month	+10.58%
1 month	+11.79%
3 months	-4.37%
6 months	-26.40%
Current year	-8.91%

1 week	0.09	0.13
1 month	0.08	0.13
Current year	0.08	0.14
1 year	0.08	0.3
3 years	0.08	0.48
5 years	0.08	1.77
10 years	0.08	5.45

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	15/02/2020
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	01/01/2009
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	01/09/2019

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	16/01/2009
Maurice Bourlion BRD	Director/Board Member	-	02/07/2009
Pierre Jérôme CHM	Chairman	-	01/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	-0.54%	+4.55%	-2.13%	-80.09%	10.14M
PENUMBRA, INC.	+0.46%	-0.51%	+29.43%	+30.81%	12.75B
GETINGE AB	-0.73%	+1.75%	+19.17%	+33.90%	7.07B
ASAHI INTECC CO., LTD.	-1.96%	+3.35%	+53.87%	+47.53%	6.89B
MINIMED GROUP, INC.	+1.64%	+1.99%	-	-	5.67B
APT MEDICAL INC.	-1.02%	+21.15%	-7.35%	+86.98%	5.51B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-3.05%	-5.25%	-29.64%	-24.38%	3.9B
NOVOCURE LIMITED	-3.18%	+1.00%	+43.74%	-45.04%	2.07B
IMPLANTICA AG	+4.24%	+8.45%	-24.36%	+131.08%	1.62B
NAKANISHI INC.	-2.10%	-9.42%	+44.29%	-10.75%	1.62B
Average	-0.63%	+2.96%	+14.11%	+18.89%	4.71B
Weighted average by Cap.	-0.52%	+3.29%	+20.48%	+34.88%

	2024	2025
Net sales	4.65M 5.43M 4.35M 3.98M 7.47M 519M 7.57M 51.38M 20.04M 261M 20.37M 19.93M 863M	3.76M 4.39M 3.52M 3.22M 6.04M 420M 6.12M 41.54M 16.2M 211M 16.47M 16.11M 697M
Net income	-3.08M -3.6M -2.88M -2.64M -4.95M -344M -5.02M -34.07M -13.29M -173M -13.51M -13.22M -572M	-2.07M -2.41M -1.93M -1.77M -3.32M -231M -3.37M -22.86M -8.91M -116M -9.06M -8.87M -384M
Net Debt	1.82M 2.12M 1.7M 1.56M 2.92M 203M 2.96M 20.1M 7.84M 102M 7.97M 7.8M 338M	-265K -310K -248K -227K -427K -29.64M -432K -2.93M -1.14M -14.89M -1.16M -1.14M -49.25M